$2.27
0.115.09%
At close: -
$2.27
00.00%
After Hours: Nov 22, 4:02 PM EDT
Comments
Loading...
Harvard Bioscience (HBIO) Forecast
NewsEarningsHarvard Bioscience (HBIO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHarvard Bioscience (NASDAQ:HBIO) Stock Quotes, Forecast and News Summary
Harvard Bioscience Stock (NASDAQ: HBIO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Harvard Bioscience (HBIO) stock?
You can purchase shares of Harvard Bioscience (NASDAQ:HBIO) through any online brokerage.
Who are Harvard Bioscience (HBIO) competitors?
Other companies in Harvard Bioscience’s space includes: Codexis (NASDAQ:CDXS), CryoPort (NASDAQ:CYRX), Personalis (NASDAQ:PSNL), Quantum-Si (NASDAQ:QSI) and Inotiv (NASDAQ:NOTV).
What is the forecast, or price target, for Harvard Bioscience (HBIO) stock?
Harvard Bioscience has a consensus price target of $6.00.
What is the current price for Harvard Bioscience (HBIO)?
The stock price for Harvard Bioscience (NASDAQ: HBIO) is $2.27 last updated November 22, 2024 at 4:02 PM EST.
Does Harvard Bioscience (HBIO) pay a dividend?
There are no upcoming dividends for Harvard Bioscience.
When is Harvard Bioscience (NASDAQ:HBIO) reporting earnings?
Harvard Bioscience’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Harvard Bioscience (HBIO) going to split?
There is no upcoming split for Harvard Bioscience.
What sector and industry does Harvard Bioscience (HBIO) operate in?
Harvard Bioscience is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.